

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 9.19379593 |
| 2 | actin-myosin filament sliding (GO:0033275) | 9.19379593 |
| 3 | actin-mediated cell contraction (GO:0070252) | 7.63365467 |
| 4 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.62795198 |
| 5 | myofibril assembly (GO:0030239) | 6.41347437 |
| 6 | sarcomere organization (GO:0045214) | 5.87930574 |
| 7 | response to inactivity (GO:0014854) | 5.49534894 |
| 8 | response to muscle activity (GO:0014850) | 5.47998771 |
| 9 | actin filament-based movement (GO:0030048) | 5.36643698 |
| 10 | striated muscle contraction (GO:0006941) | 5.35103806 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.33143281 |
| 12 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 5.22599441 |
| 13 | cardiac myofibril assembly (GO:0055003) | 4.84115431 |
| 14 | skeletal muscle fiber development (GO:0048741) | 4.81306146 |
| 15 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.71164869 |
| 16 | skeletal muscle adaptation (GO:0043501) | 4.68103753 |
| 17 | actomyosin structure organization (GO:0031032) | 4.35184561 |
| 18 | muscle fiber development (GO:0048747) | 4.28426706 |
| 19 | plasma membrane repair (GO:0001778) | 4.24346129 |
| 20 | muscle contraction (GO:0006936) | 4.18967490 |
| 21 | creatine metabolic process (GO:0006600) | 3.86874101 |
| 22 | cardiac muscle hypertrophy (GO:0003300) | 3.83634405 |
| 23 | muscle system process (GO:0003012) | 3.82512344 |
| 24 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.79232241 |
| 25 | skeletal muscle tissue development (GO:0007519) | 3.76993496 |
| 26 | glycogen catabolic process (GO:0005980) | 3.76504843 |
| 27 | striated muscle hypertrophy (GO:0014897) | 3.65957970 |
| 28 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.63314609 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.63062439 |
| 30 | muscle cell cellular homeostasis (GO:0046716) | 3.61710003 |
| 31 | startle response (GO:0001964) | 3.61045806 |
| 32 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.59498656 |
| 33 | regulation of actin filament-based movement (GO:1903115) | 3.57544037 |
| 34 | regulation of sarcomere organization (GO:0060297) | 3.57163989 |
| 35 | presynaptic membrane assembly (GO:0097105) | 3.56133059 |
| 36 | ubiquinone biosynthetic process (GO:0006744) | 3.55789075 |
| 37 | cardiac muscle contraction (GO:0060048) | 3.55391660 |
| 38 | skeletal muscle tissue regeneration (GO:0043403) | 3.50800151 |
| 39 | glucan catabolic process (GO:0009251) | 3.47950704 |
| 40 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.45218526 |
| 41 | glycogen biosynthetic process (GO:0005978) | 3.42670543 |
| 42 | glucan biosynthetic process (GO:0009250) | 3.42670543 |
| 43 | postsynaptic membrane organization (GO:0001941) | 3.39894042 |
| 44 | striated muscle adaptation (GO:0014888) | 3.39825505 |
| 45 | adult heart development (GO:0007512) | 3.39095886 |
| 46 | superoxide anion generation (GO:0042554) | 3.32997167 |
| 47 | striated muscle cell development (GO:0055002) | 3.29722833 |
| 48 | muscle structure development (GO:0061061) | 3.28925535 |
| 49 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.24515097 |
| 50 | ubiquinone metabolic process (GO:0006743) | 3.23066709 |
| 51 | cellular polysaccharide catabolic process (GO:0044247) | 3.22846626 |
| 52 | muscle hypertrophy (GO:0014896) | 3.22334866 |
| 53 | muscle organ development (GO:0007517) | 3.22015222 |
| 54 | regulation of activation of Janus kinase activity (GO:0010533) | 3.21603671 |
| 55 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.19005320 |
| 56 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16581345 |
| 57 | fatty acid transmembrane transport (GO:1902001) | 3.14324787 |
| 58 | regulation of striated muscle contraction (GO:0006942) | 3.14189449 |
| 59 | regulation of hexokinase activity (GO:1903299) | 3.13648804 |
| 60 | regulation of glucokinase activity (GO:0033131) | 3.13648804 |
| 61 | negative regulation of mast cell activation (GO:0033004) | 3.12942773 |
| 62 | carnitine shuttle (GO:0006853) | 3.12504200 |
| 63 | cardiac muscle cell development (GO:0055013) | 3.05567258 |
| 64 | presynaptic membrane organization (GO:0097090) | 3.03509266 |
| 65 | neuronal action potential propagation (GO:0019227) | 3.02365689 |
| 66 | urinary tract smooth muscle contraction (GO:0014848) | 3.02081945 |
| 67 | striated muscle atrophy (GO:0014891) | 3.01481460 |
| 68 | otic vesicle formation (GO:0030916) | 3.01217377 |
| 69 | regulation of synapse maturation (GO:0090128) | 2.99920512 |
| 70 | protein localization to cilium (GO:0061512) | 2.98942571 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.98584847 |
| 72 | atrial cardiac muscle cell action potential (GO:0086014) | 2.97812974 |
| 73 | membrane depolarization during action potential (GO:0086010) | 2.96493188 |
| 74 | auditory receptor cell stereocilium organization (GO:0060088) | 2.95752629 |
| 75 | response to activity (GO:0014823) | 2.95502119 |
| 76 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.95394034 |
| 77 | polysaccharide catabolic process (GO:0000272) | 2.93535246 |
| 78 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.90637199 |
| 79 | myotube differentiation (GO:0014902) | 2.90154724 |
| 80 | behavioral response to nicotine (GO:0035095) | 2.88070244 |
| 81 | quinone biosynthetic process (GO:1901663) | 2.87878761 |
| 82 | regulation of skeletal muscle contraction (GO:0014819) | 2.87765964 |
| 83 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.86551201 |
| 84 | motile cilium assembly (GO:0044458) | 2.86452800 |
| 85 | energy homeostasis (GO:0097009) | 2.86321970 |
| 86 | cornea development in camera-type eye (GO:0061303) | 2.85679610 |
| 87 | somite development (GO:0061053) | 2.84864795 |
| 88 | skeletal muscle contraction (GO:0003009) | 2.83231516 |
| 89 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.83228725 |
| 90 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.81772415 |
| 91 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.81772415 |
| 92 | adenosine metabolic process (GO:0046085) | 2.80858131 |
| 93 | interkinetic nuclear migration (GO:0022027) | 2.79559396 |
| 94 | muscle atrophy (GO:0014889) | 2.78868001 |
| 95 | histone H3-K4 trimethylation (GO:0080182) | 2.78855711 |
| 96 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.77454831 |
| 97 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.77454831 |
| 98 | opioid receptor signaling pathway (GO:0038003) | 2.76518916 |
| 99 | regulation of membrane repolarization (GO:0060306) | 2.75772073 |
| 100 | cardiac cell development (GO:0055006) | 2.75768426 |
| 101 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75604265 |
| 102 | positive regulation of cation channel activity (GO:2001259) | 2.73932453 |
| 103 | muscle tissue morphogenesis (GO:0060415) | 2.72843914 |
| 104 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.72642813 |
| 105 | cranial nerve structural organization (GO:0021604) | 2.71986047 |
| 106 | muscle cell development (GO:0055001) | 2.71925572 |
| 107 | response to caffeine (GO:0031000) | 2.71617421 |
| 108 | carnitine transmembrane transport (GO:1902603) | 2.71422391 |
| 109 | relaxation of muscle (GO:0090075) | 2.70858967 |
| 110 | pyrimidine dimer repair (GO:0006290) | 2.68921713 |
| 111 | glycogen metabolic process (GO:0005977) | 2.68752863 |
| 112 | regulation of sequestering of triglyceride (GO:0010889) | 2.68131649 |
| 113 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.66686805 |
| 114 | synaptic transmission, cholinergic (GO:0007271) | 2.66499498 |
| 115 | neuron cell-cell adhesion (GO:0007158) | 2.66200318 |
| 116 | dentate gyrus development (GO:0021542) | 2.65259710 |
| 117 | regulation of energy homeostasis (GO:2000505) | 2.64729557 |
| 118 | myoblast fusion (GO:0007520) | 2.64381964 |
| 119 | negative regulation of muscle contraction (GO:0045932) | 2.64341928 |
| 120 | aggressive behavior (GO:0002118) | 2.60305663 |
| 121 | protein complex biogenesis (GO:0070271) | 2.59079741 |
| 122 | negative regulation of T cell mediated immunity (GO:0002710) | 2.57558753 |
| 123 | regulation of penile erection (GO:0060405) | 2.56789804 |
| 124 | regulation of relaxation of muscle (GO:1901077) | 2.55357107 |
| 125 | protein localization to synapse (GO:0035418) | 2.54660074 |
| 126 | nucleotide transmembrane transport (GO:1901679) | 2.53703441 |
| 127 | mitochondrion distribution (GO:0048311) | 2.53699579 |
| 128 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.51257503 |
| 129 | cAMP catabolic process (GO:0006198) | 2.49765054 |
| 130 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.49524270 |
| 131 | cytochrome complex assembly (GO:0017004) | 2.49487189 |
| 132 | glutamate receptor signaling pathway (GO:0007215) | 2.49486117 |
| 133 | prostate gland growth (GO:0060736) | 2.48867045 |
| 134 | detection of molecule of bacterial origin (GO:0032490) | 2.45786457 |
| 135 | negative regulation of dendrite development (GO:2000171) | 2.45164977 |
| 136 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.43752479 |
| 137 | inner ear receptor stereocilium organization (GO:0060122) | 2.43664213 |
| 138 | L-fucose metabolic process (GO:0042354) | 2.43272244 |
| 139 | L-fucose catabolic process (GO:0042355) | 2.43272244 |
| 140 | fucose catabolic process (GO:0019317) | 2.43272244 |
| 141 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.42120746 |
| 142 | synaptic transmission, glutamatergic (GO:0035249) | 2.42008918 |
| 143 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.41657623 |
| 144 | neuromuscular synaptic transmission (GO:0007274) | 2.41275605 |
| 145 | neuron-neuron synaptic transmission (GO:0007270) | 2.40691336 |
| 146 | positive regulation of uterine smooth muscle contraction (GO:0070474) | 2.40044873 |
| 147 | cyclic nucleotide catabolic process (GO:0009214) | 2.38614148 |
| 148 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.37080798 |
| 149 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.36301612 |
| 150 | regulation of cell communication by electrical coupling (GO:0010649) | 2.35659120 |
| 151 | regulation of fever generation (GO:0031620) | 2.34861398 |
| 152 | calcium ion import (GO:0070509) | 2.34622082 |
| 153 | inner ear receptor cell differentiation (GO:0060113) | 2.34299896 |
| 154 | glycosphingolipid catabolic process (GO:0046479) | 2.34214472 |
| 155 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.32805136 |
| 156 | histamine secretion (GO:0001821) | 2.32601837 |
| 157 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.31285846 |
| 158 | reflex (GO:0060004) | 2.31284228 |
| 159 | behavioral response to pain (GO:0048266) | 2.30923075 |
| 160 | cell differentiation involved in metanephros development (GO:0072202) | 2.29195811 |
| 161 | regulation of synapse assembly (GO:0051963) | 2.27187481 |
| 162 | dendritic cell chemotaxis (GO:0002407) | 2.26909982 |
| 163 | mechanoreceptor differentiation (GO:0042490) | 2.26367347 |
| 164 | regulation of male gonad development (GO:2000018) | 2.25878129 |
| 165 | myotube cell development (GO:0014904) | 2.25821603 |
| 166 | polyketide metabolic process (GO:0030638) | 2.25511307 |
| 167 | doxorubicin metabolic process (GO:0044598) | 2.25511307 |
| 168 | daunorubicin metabolic process (GO:0044597) | 2.25511307 |
| 169 | extracellular negative regulation of signal transduction (GO:1900116) | 2.25262835 |
| 170 | extracellular regulation of signal transduction (GO:1900115) | 2.25262835 |
| 171 | tRNA methylation (GO:0030488) | 2.24017365 |
| 172 | detection of other organism (GO:0098543) | 2.23720287 |
| 173 | facial nerve structural organization (GO:0021612) | 2.23353097 |
| 174 | ganglion development (GO:0061548) | 2.22033570 |
| 175 | positive regulation of heat generation (GO:0031652) | 2.21718017 |
| 176 | detection of calcium ion (GO:0005513) | 2.21254995 |
| 177 | female mating behavior (GO:0060180) | 2.21105100 |
| 178 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.20752633 |
| 179 | negative regulation of myoblast differentiation (GO:0045662) | 2.20638057 |
| 180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.20289229 |
| 181 | centriole assembly (GO:0098534) | 2.19930585 |
| 182 | detection of light stimulus involved in visual perception (GO:0050908) | 2.19469726 |
| 183 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.19469726 |
| 184 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.14137322 |
| 185 | regulation of mast cell activation (GO:0033003) | 2.14044369 |
| 186 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.13159956 |
| 187 | NADH dehydrogenase complex assembly (GO:0010257) | 2.13155438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * GBX2_23144817_ChIP-Seq_PC3_Human | 4.51734153 |
| 2 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 3.14383650 |
| 3 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 3.12662231 |
| 4 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.84721347 |
| 5 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.81456080 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.75585313 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.75308191 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.67240873 |
| 9 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.65208824 |
| 10 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.55103459 |
| 11 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.52298697 |
| 12 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.43110356 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.28127135 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.18517419 |
| 15 | * P300_19829295_ChIP-Seq_ESCs_Human | 2.11778733 |
| 16 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 2.10312393 |
| 17 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 2.05064626 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.96981094 |
| 19 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.96156990 |
| 20 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.93118404 |
| 21 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.91997737 |
| 22 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.91025176 |
| 23 | VDR_22108803_ChIP-Seq_LS180_Human | 1.85892302 |
| 24 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85145933 |
| 25 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.84736602 |
| 26 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.80801614 |
| 27 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.80760642 |
| 28 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.80485659 |
| 29 | FUS_26573619_Chip-Seq_HEK293_Human | 1.80405449 |
| 30 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.78317506 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.75911749 |
| 32 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74423566 |
| 33 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.74040574 |
| 34 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.73577050 |
| 35 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.71793789 |
| 36 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.71390563 |
| 37 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.69361189 |
| 38 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.69008779 |
| 39 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.68261388 |
| 40 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.68063889 |
| 41 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.64457071 |
| 42 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.64023939 |
| 43 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.63935369 |
| 44 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.62951721 |
| 45 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.61484065 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.60236407 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.59966707 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.57042895 |
| 49 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.56656479 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.56656479 |
| 51 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.55376038 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.53601899 |
| 53 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.53220981 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.52653771 |
| 55 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52519138 |
| 56 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52188388 |
| 57 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.47403973 |
| 58 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.46153544 |
| 59 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.45743700 |
| 60 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.45136558 |
| 61 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.44428271 |
| 62 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.44035558 |
| 63 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.44035558 |
| 64 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.42583478 |
| 65 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.42319890 |
| 66 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41615892 |
| 67 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.41337520 |
| 68 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.40735256 |
| 69 | EWS_26573619_Chip-Seq_HEK293_Human | 1.38958269 |
| 70 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37073674 |
| 71 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.36612296 |
| 72 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.36612296 |
| 73 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36201643 |
| 74 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.36003321 |
| 75 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.35834560 |
| 76 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.34264013 |
| 77 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.34154450 |
| 78 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.32336768 |
| 79 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.31613007 |
| 80 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.31462603 |
| 81 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31216355 |
| 82 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.31147677 |
| 83 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.30606207 |
| 84 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.30606207 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30081908 |
| 86 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.29787676 |
| 87 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.29490533 |
| 88 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.29132339 |
| 89 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.28866536 |
| 90 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.28660152 |
| 91 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.28406467 |
| 92 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.28267530 |
| 93 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.27458454 |
| 94 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.27353465 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 1.27069349 |
| 96 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26893622 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.25439817 |
| 98 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25004149 |
| 99 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.23734990 |
| 100 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.22805401 |
| 101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.22366416 |
| 102 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.22023065 |
| 103 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.21506572 |
| 104 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.21330423 |
| 105 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 1.20781122 |
| 106 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20550536 |
| 107 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.19305949 |
| 108 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.17368411 |
| 109 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.17120513 |
| 110 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.16211066 |
| 111 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.15991667 |
| 112 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15749638 |
| 113 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.15735411 |
| 114 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.15396667 |
| 115 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.15333469 |
| 116 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.14900218 |
| 117 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.14433118 |
| 118 | JUN_21703547_ChIP-Seq_K562_Human | 1.13120146 |
| 119 | KDM2B_26808549_Chip-Seq_REH_Human | 1.11817266 |
| 120 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.11373422 |
| 121 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.11001831 |
| 122 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.10762068 |
| 123 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.09239630 |
| 124 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.08732266 |
| 125 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08582228 |
| 126 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.08338748 |
| 127 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.08066612 |
| 128 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.08021260 |
| 129 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.07856057 |
| 130 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06532711 |
| 131 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.05615227 |
| 132 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.99824570 |
| 133 | TBL1_22424771_ChIP-Seq_293T_Human | 0.98814498 |
| 134 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.98019789 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.95994564 |
| 136 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.95267304 |
| 137 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.95007648 |
| 138 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.94712593 |
| 139 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.93935265 |
| 140 | NFYB_21822215_ChIP-Seq_K562_Human | 0.93932826 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003787_abnormal_imprinting | 3.72748721 |
| 2 | MP0001188_hyperpigmentation | 3.70788600 |
| 3 | MP0006292_abnormal_olfactory_placode | 3.45736863 |
| 4 | MP0004036_abnormal_muscle_relaxation | 3.37859175 |
| 5 | MP0002106_abnormal_muscle_physiology | 3.09960688 |
| 6 | MP0005646_abnormal_pituitary_gland | 3.06060455 |
| 7 | MP0003136_yellow_coat_color | 3.04848318 |
| 8 | MP0005670_abnormal_white_adipose | 2.96119967 |
| 9 | MP0004130_abnormal_muscle_cell | 2.76422373 |
| 10 | MP0002837_dystrophic_cardiac_calcinosis | 2.64414301 |
| 11 | MP0000566_synostosis | 2.63477736 |
| 12 | MP0005620_abnormal_muscle_contractility | 2.62864923 |
| 13 | MP0000747_muscle_weakness | 2.62635456 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.56969851 |
| 15 | MP0004084_abnormal_cardiac_muscle | 2.55797823 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.48927924 |
| 17 | MP0002269_muscular_atrophy | 2.44461384 |
| 18 | MP0003880_abnormal_central_pattern | 2.43424171 |
| 19 | MP0005171_absent_coat_pigmentation | 2.38732824 |
| 20 | MP0000759_abnormal_skeletal_muscle | 2.35531157 |
| 21 | MP0005409_darkened_coat_color | 2.27112298 |
| 22 | MP0002736_abnormal_nociception_after | 2.14232316 |
| 23 | MP0009697_abnormal_copulation | 2.13215627 |
| 24 | MP0002876_abnormal_thyroid_physiology | 2.12598279 |
| 25 | MP0005645_abnormal_hypothalamus_physiol | 2.07517642 |
| 26 | MP0002102_abnormal_ear_morphology | 2.01953022 |
| 27 | MP0005330_cardiomyopathy | 1.99454314 |
| 28 | MP0001968_abnormal_touch/_nociception | 1.96326501 |
| 29 | MP0002735_abnormal_chemical_nociception | 1.89090250 |
| 30 | MP0001986_abnormal_taste_sensitivity | 1.83093958 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.80075817 |
| 32 | MP0000015_abnormal_ear_pigmentation | 1.79531819 |
| 33 | MP0008789_abnormal_olfactory_epithelium | 1.79038797 |
| 34 | MP0002277_abnormal_respiratory_mucosa | 1.78356172 |
| 35 | MP0003879_abnormal_hair_cell | 1.75138281 |
| 36 | MP0009745_abnormal_behavioral_response | 1.73459953 |
| 37 | MP0005394_taste/olfaction_phenotype | 1.67889876 |
| 38 | MP0005499_abnormal_olfactory_system | 1.67889876 |
| 39 | MP0004233_abnormal_muscle_weight | 1.66692455 |
| 40 | MP0002108_abnormal_muscle_morphology | 1.63948944 |
| 41 | MP0002163_abnormal_gland_morphology | 1.63426316 |
| 42 | MP0004145_abnormal_muscle_electrophysio | 1.63316867 |
| 43 | MP0001984_abnormal_olfaction | 1.62889568 |
| 44 | MP0002972_abnormal_cardiac_muscle | 1.61544787 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.59799498 |
| 46 | MP0003183_abnormal_peptide_metabolism | 1.58490231 |
| 47 | MP0002638_abnormal_pupillary_reflex | 1.58030034 |
| 48 | MP0004147_increased_porphyrin_level | 1.57490516 |
| 49 | MP0008877_abnormal_DNA_methylation | 1.55987312 |
| 50 | MP0003646_muscle_fatigue | 1.51308750 |
| 51 | MP0006036_abnormal_mitochondrial_physio | 1.48087920 |
| 52 | MP0001502_abnormal_circadian_rhythm | 1.45889153 |
| 53 | MP0001486_abnormal_startle_reflex | 1.44521575 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.42435331 |
| 55 | MP0009046_muscle_twitch | 1.41039688 |
| 56 | MP0000372_irregular_coat_pigmentation | 1.40557546 |
| 57 | MP0005266_abnormal_metabolism | 1.40351978 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 1.35722325 |
| 59 | MP0005551_abnormal_eye_electrophysiolog | 1.34475951 |
| 60 | MP0004510_myositis | 1.32388471 |
| 61 | MP0001963_abnormal_hearing_physiology | 1.31251577 |
| 62 | MP0000733_abnormal_muscle_development | 1.30560481 |
| 63 | MP0002572_abnormal_emotion/affect_behav | 1.29980278 |
| 64 | MP0008775_abnormal_heart_ventricle | 1.28577003 |
| 65 | MP0001905_abnormal_dopamine_level | 1.27118364 |
| 66 | MP0003137_abnormal_impulse_conducting | 1.25031468 |
| 67 | MP0000026_abnormal_inner_ear | 1.24300891 |
| 68 | MP0000013_abnormal_adipose_tissue | 1.23947107 |
| 69 | MP0002063_abnormal_learning/memory/cond | 1.21470181 |
| 70 | MP0002067_abnormal_sensory_capabilities | 1.20353835 |
| 71 | MP0004043_abnormal_pH_regulation | 1.20339432 |
| 72 | MP0002064_seizures | 1.18806991 |
| 73 | MP0001661_extended_life_span | 1.18794383 |
| 74 | MP0003121_genomic_imprinting | 1.18359870 |
| 75 | MP0002148_abnormal_hypersensitivity_rea | 1.14300377 |
| 76 | MP0005451_abnormal_body_composition | 1.12866511 |
| 77 | MP0003950_abnormal_plasma_membrane | 1.11945810 |
| 78 | MP0004142_abnormal_muscle_tone | 1.11267232 |
| 79 | MP0003122_maternal_imprinting | 1.09628386 |
| 80 | MP0003635_abnormal_synaptic_transmissio | 1.09419390 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 1.08227229 |
| 82 | MP0002272_abnormal_nervous_system | 1.07401364 |
| 83 | MP0000749_muscle_degeneration | 1.06948977 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 1.06489238 |
| 85 | MP0002734_abnormal_mechanical_nocicepti | 1.06429238 |
| 86 | MP0000631_abnormal_neuroendocrine_gland | 1.06232086 |
| 87 | MP0001835_abnormal_antigen_presentation | 1.05548609 |
| 88 | MP0003941_abnormal_skin_development | 1.03526103 |
| 89 | MP0001544_abnormal_cardiovascular_syste | 1.01492720 |
| 90 | MP0005385_cardiovascular_system_phenoty | 1.01492720 |
| 91 | MP0002822_catalepsy | 1.01470342 |
| 92 | MP0004085_abnormal_heartbeat | 1.00036806 |
| 93 | MP0001485_abnormal_pinna_reflex | 0.98881937 |
| 94 | MP0001529_abnormal_vocalization | 0.95651417 |
| 95 | MP0003045_fibrosis | 0.94642241 |
| 96 | MP0005167_abnormal_blood-brain_barrier | 0.93900790 |
| 97 | MP0004484_altered_response_of | 0.92371062 |
| 98 | MP0009785_altered_susceptibility_to | 0.91963576 |
| 99 | MP0009250_abnormal_appendicular_skeleto | 0.90867071 |
| 100 | MP0005187_abnormal_penis_morphology | 0.89754806 |
| 101 | MP0003195_calcinosis | 0.89395359 |
| 102 | MP0000751_myopathy | 0.89327444 |
| 103 | MP0004859_abnormal_synaptic_plasticity | 0.88708385 |
| 104 | MP0002095_abnormal_skin_pigmentation | 0.88233339 |
| 105 | MP0001186_pigmentation_phenotype | 0.87325328 |
| 106 | MP0002557_abnormal_social/conspecific_i | 0.87189084 |
| 107 | MP0001790_abnormal_immune_system | 0.85947293 |
| 108 | MP0005387_immune_system_phenotype | 0.85947293 |
| 109 | MP0003724_increased_susceptibility_to | 0.84753657 |
| 110 | MP0010630_abnormal_cardiac_muscle | 0.84720220 |
| 111 | MP0005423_abnormal_somatic_nervous | 0.83871124 |
| 112 | MP0008872_abnormal_physiological_respon | 0.83731205 |
| 113 | MP0005253_abnormal_eye_physiology | 0.83249877 |
| 114 | MP0005671_abnormal_response_to | 0.83189907 |
| 115 | MP0006072_abnormal_retinal_apoptosis | 0.80864337 |
| 116 | MP0002971_abnormal_brown_adipose | 0.79524859 |
| 117 | MP0000049_abnormal_middle_ear | 0.78143747 |
| 118 | MP0008058_abnormal_DNA_repair | 0.77187441 |
| 119 | MP0003221_abnormal_cardiomyocyte_apopto | 0.76751691 |
| 120 | MP0001440_abnormal_grooming_behavior | 0.76558925 |
| 121 | MP0004215_abnormal_myocardial_fiber | 0.76479238 |
| 122 | MP0002132_abnormal_respiratory_system | 0.76326806 |
| 123 | MP0006138_congestive_heart_failure | 0.76186135 |
| 124 | MP0004270_analgesia | 0.74942618 |
| 125 | MP0004924_abnormal_behavior | 0.74635887 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.74635887 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.74284668 |
| 128 | MP0001346_abnormal_lacrimal_gland | 0.72681935 |
| 129 | MP0008260_abnormal_autophagy | 0.71133427 |
| 130 | MP0002127_abnormal_cardiovascular_syste | 0.70156783 |
| 131 | MP0005083_abnormal_biliary_tract | 0.69082757 |
| 132 | MP0000516_abnormal_urinary_system | 0.68165371 |
| 133 | MP0005367_renal/urinary_system_phenotyp | 0.68165371 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.67989309 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.67980633 |
| 136 | MP0000230_abnormal_systemic_arterial | 0.66963669 |
| 137 | MP0008007_abnormal_cellular_replicative | 0.65242701 |
| 138 | MP0009764_decreased_sensitivity_to | 0.64434064 |
| 139 | MP0002075_abnormal_coat/hair_pigmentati | 0.64359323 |
| 140 | MP0008004_abnormal_stomach_pH | 0.62885310 |
| 141 | MP0003943_abnormal_hepatobiliary_system | 0.62658483 |
| 142 | MP0002138_abnormal_hepatobiliary_system | 0.62637410 |
| 143 | MP0000427_abnormal_hair_cycle | 0.62212556 |
| 144 | MP0004134_abnormal_chest_morphology | 0.60494538 |
| 145 | MP0005369_muscle_phenotype | 0.60252140 |
| 146 | MP0002938_white_spotting | 0.56183983 |
| 147 | MP0004885_abnormal_endolymph | 0.55813192 |
| 148 | MP0000569_abnormal_digit_pigmentation | 0.55149673 |
| 149 | MP0001299_abnormal_eye_distance/ | 0.53089670 |
| 150 | MP0002752_abnormal_somatic_nervous | 0.50035789 |
| 151 | MP0002078_abnormal_glucose_homeostasis | 0.47303062 |
| 152 | MP0003011_delayed_dark_adaptation | 0.46188324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced muscle cramps (HP:0003710) | 6.80922195 |
| 2 | Distal arthrogryposis (HP:0005684) | 5.76907981 |
| 3 | EMG: myopathic abnormalities (HP:0003458) | 4.78024655 |
| 4 | Rimmed vacuoles (HP:0003805) | 4.72337504 |
| 5 | Myopathic facies (HP:0002058) | 4.63155489 |
| 6 | Febrile seizures (HP:0002373) | 4.59374855 |
| 7 | Muscle fiber splitting (HP:0003555) | 4.14139621 |
| 8 | Neck muscle weakness (HP:0000467) | 3.98027453 |
| 9 | Abnormality of the columella (HP:0009929) | 3.97722578 |
| 10 | Myoglobinuria (HP:0002913) | 3.92263398 |
| 11 | Round ear (HP:0100830) | 3.92025546 |
| 12 | Focal motor seizures (HP:0011153) | 3.89057552 |
| 13 | Rhabdomyolysis (HP:0003201) | 3.86734945 |
| 14 | Abnormal hair whorl (HP:0010721) | 3.84058371 |
| 15 | Hyporeflexia of lower limbs (HP:0002600) | 3.73041131 |
| 16 | Epileptic encephalopathy (HP:0200134) | 3.64169305 |
| 17 | Ulnar deviation of the wrist (HP:0003049) | 3.54876871 |
| 18 | Frequent falls (HP:0002359) | 3.51527959 |
| 19 | Absent phalangeal crease (HP:0006109) | 3.47996608 |
| 20 | Muscle fiber inclusion bodies (HP:0100299) | 3.46016580 |
| 21 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.43326765 |
| 22 | Difficulty running (HP:0009046) | 3.38315276 |
| 23 | Nemaline bodies (HP:0003798) | 3.32012946 |
| 24 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.14849743 |
| 25 | Hypoplasia of the fovea (HP:0007750) | 3.14702795 |
| 26 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 3.14702795 |
| 27 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.05854911 |
| 28 | Septo-optic dysplasia (HP:0100842) | 3.04500985 |
| 29 | Abnormal finger flexion creases (HP:0006143) | 2.98784134 |
| 30 | Areflexia of lower limbs (HP:0002522) | 2.93693120 |
| 31 | Calcaneovalgus deformity (HP:0001848) | 2.89171987 |
| 32 | Chromsome breakage (HP:0040012) | 2.84011036 |
| 33 | Myotonia (HP:0002486) | 2.80795927 |
| 34 | Hypothermia (HP:0002045) | 2.80579366 |
| 35 | Hyperventilation (HP:0002883) | 2.78479766 |
| 36 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.76273013 |
| 37 | Subaortic stenosis (HP:0001682) | 2.76273013 |
| 38 | Malignant hyperthermia (HP:0002047) | 2.75319211 |
| 39 | Fair hair (HP:0002286) | 2.74850232 |
| 40 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.74460727 |
| 41 | Abnormality of the fovea (HP:0000493) | 2.67844854 |
| 42 | Generalized muscle weakness (HP:0003324) | 2.66741178 |
| 43 | Long nose (HP:0003189) | 2.65080697 |
| 44 | Deformed tarsal bones (HP:0008119) | 2.63498786 |
| 45 | Muscle stiffness (HP:0003552) | 2.62942815 |
| 46 | Atonic seizures (HP:0010819) | 2.62590636 |
| 47 | Hyperkalemia (HP:0002153) | 2.56911345 |
| 48 | Optic nerve hypoplasia (HP:0000609) | 2.55946167 |
| 49 | Aplasia cutis congenita (HP:0001057) | 2.52635757 |
| 50 | Increased connective tissue (HP:0009025) | 2.49303548 |
| 51 | Bundle branch block (HP:0011710) | 2.47986414 |
| 52 | Muscular dystrophy (HP:0003560) | 2.47445922 |
| 53 | Sudden death (HP:0001699) | 2.47388122 |
| 54 | Dry hair (HP:0011359) | 2.46379871 |
| 55 | Short middle phalanx of the 5th finger (HP:0004220) | 2.42004515 |
| 56 | True hermaphroditism (HP:0010459) | 2.39862198 |
| 57 | Increased variability in muscle fiber diameter (HP:0003557) | 2.39253389 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.38864300 |
| 59 | Abnormality of incisor morphology (HP:0011063) | 2.33151944 |
| 60 | Exercise-induced myalgia (HP:0003738) | 2.32727276 |
| 61 | Blue irides (HP:0000635) | 2.32315186 |
| 62 | Type 2 muscle fiber atrophy (HP:0003554) | 2.31335834 |
| 63 | Abnormality of the nasal septum (HP:0000419) | 2.30829226 |
| 64 | Medial flaring of the eyebrow (HP:0010747) | 2.29020839 |
| 65 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.24238742 |
| 66 | Congenital stationary night blindness (HP:0007642) | 2.24202939 |
| 67 | Long clavicles (HP:0000890) | 2.22227871 |
| 68 | Osteomalacia (HP:0002749) | 2.21190670 |
| 69 | Generalized hypopigmentation of hair (HP:0011358) | 2.19557221 |
| 70 | Retrobulbar optic neuritis (HP:0100654) | 2.17798585 |
| 71 | Optic neuritis (HP:0100653) | 2.17798585 |
| 72 | Abnormality of DNA repair (HP:0003254) | 2.17299205 |
| 73 | Congenital sensorineural hearing impairment (HP:0008527) | 2.15908723 |
| 74 | Slender build (HP:0001533) | 2.14324029 |
| 75 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 2.14173911 |
| 76 | Chronic hepatic failure (HP:0100626) | 2.13793103 |
| 77 | Protruding tongue (HP:0010808) | 2.13384353 |
| 78 | Nephrogenic diabetes insipidus (HP:0009806) | 2.12317117 |
| 79 | Fatigable weakness (HP:0003473) | 2.11757257 |
| 80 | Abnormality of the neuromuscular junction (HP:0003398) | 2.11757257 |
| 81 | Calf muscle hypertrophy (HP:0008981) | 2.10581074 |
| 82 | Lip pit (HP:0100267) | 2.09374982 |
| 83 | Nonprogressive disorder (HP:0003680) | 2.09111012 |
| 84 | Proximal amyotrophy (HP:0007126) | 2.08298321 |
| 85 | White forelock (HP:0002211) | 2.03781443 |
| 86 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.03224657 |
| 87 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.02785678 |
| 88 | Decreased central vision (HP:0007663) | 2.01882095 |
| 89 | Patchy hypopigmentation of hair (HP:0011365) | 1.98863514 |
| 90 | Hip contracture (HP:0003273) | 1.97425161 |
| 91 | Gowers sign (HP:0003391) | 1.96994458 |
| 92 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.96890878 |
| 93 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.96879363 |
| 94 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.96879363 |
| 95 | Dilated cardiomyopathy (HP:0001644) | 1.96846504 |
| 96 | Corneal dystrophy (HP:0001131) | 1.96394205 |
| 97 | Hypoplastic ischia (HP:0003175) | 1.96142366 |
| 98 | Severe visual impairment (HP:0001141) | 1.95164004 |
| 99 | Abnormality of the renal collecting system (HP:0004742) | 1.95022726 |
| 100 | Fetal akinesia sequence (HP:0001989) | 1.94128517 |
| 101 | Keratitis (HP:0000491) | 1.93237947 |
| 102 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.91827779 |
| 103 | Congenital primary aphakia (HP:0007707) | 1.89944325 |
| 104 | Scapular winging (HP:0003691) | 1.89061292 |
| 105 | Bulbar palsy (HP:0001283) | 1.88653558 |
| 106 | Facial diplegia (HP:0001349) | 1.88245521 |
| 107 | Gait imbalance (HP:0002141) | 1.88155952 |
| 108 | Shoulder girdle muscle weakness (HP:0003547) | 1.87517903 |
| 109 | Limb-girdle muscle atrophy (HP:0003797) | 1.86058343 |
| 110 | Large for gestational age (HP:0001520) | 1.85497023 |
| 111 | Alveolar cell carcinoma (HP:0006519) | 1.85027994 |
| 112 | Narrow nasal bridge (HP:0000446) | 1.84243257 |
| 113 | Abnormality of the frontal sinuses (HP:0002687) | 1.84173657 |
| 114 | Asymmetric septal hypertrophy (HP:0001670) | 1.84136841 |
| 115 | Abnormality of the calf musculature (HP:0001430) | 1.83645317 |
| 116 | Distal lower limb muscle weakness (HP:0009053) | 1.83406644 |
| 117 | Growth hormone deficiency (HP:0000824) | 1.83332976 |
| 118 | Lipoatrophy (HP:0100578) | 1.81431730 |
| 119 | Abnormality of the ischium (HP:0003174) | 1.80989606 |
| 120 | Oligomenorrhea (HP:0000876) | 1.79376127 |
| 121 | Type 1 muscle fiber predominance (HP:0003803) | 1.78726775 |
| 122 | Median cleft lip (HP:0000161) | 1.78617593 |
| 123 | Ectropion (HP:0000656) | 1.75615951 |
| 124 | Duplicated collecting system (HP:0000081) | 1.75103273 |
| 125 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 1.74640919 |
| 126 | Increased IgM level (HP:0003496) | 1.74117980 |
| 127 | Aplasia/Hypoplasia affecting the fundus (HP:0008057) | 1.73365333 |
| 128 | Abnormality of alanine metabolism (HP:0010916) | 1.73300492 |
| 129 | Hyperalaninemia (HP:0003348) | 1.73300492 |
| 130 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.73300492 |
| 131 | Pelvic girdle muscle weakness (HP:0003749) | 1.72371800 |
| 132 | Absent/shortened dynein arms (HP:0200106) | 1.72340349 |
| 133 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.72340349 |
| 134 | Muscle fiber atrophy (HP:0100295) | 1.71620897 |
| 135 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.71523603 |
| 136 | Pancreatic cysts (HP:0001737) | 1.71289508 |
| 137 | Molar tooth sign on MRI (HP:0002419) | 1.69680319 |
| 138 | Abnormality of midbrain morphology (HP:0002418) | 1.69680319 |
| 139 | Waddling gait (HP:0002515) | 1.69419209 |
| 140 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.68537709 |
| 141 | Morphological abnormality of the middle ear (HP:0008609) | 1.67802584 |
| 142 | Abnormality of molar (HP:0011077) | 1.67567525 |
| 143 | Abnormality of molar morphology (HP:0011070) | 1.67567525 |
| 144 | Slow-growing hair (HP:0002217) | 1.67410257 |
| 145 | Abnormality of hair growth rate (HP:0011363) | 1.67410257 |
| 146 | Broad-based gait (HP:0002136) | 1.67156128 |
| 147 | Pancreatic fibrosis (HP:0100732) | 1.65615095 |
| 148 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.65284458 |
| 149 | Abnormality of the right ventricle (HP:0001707) | 1.63479980 |
| 150 | Progressive cerebellar ataxia (HP:0002073) | 1.62450312 |
| 151 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.62284563 |
| 152 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.61273922 |
| 153 | Steppage gait (HP:0003376) | 1.60968289 |
| 154 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.60807103 |
| 155 | Left ventricular hypertrophy (HP:0001712) | 1.59697300 |
| 156 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.59263749 |
| 157 | Aplasia/Hypoplasia of the lens (HP:0008063) | 1.59250156 |
| 158 | Abnormality of potassium homeostasis (HP:0011042) | 1.59239711 |
| 159 | Abnormality of the incisor (HP:0000676) | 1.58869648 |
| 160 | Nephronophthisis (HP:0000090) | 1.58679735 |
| 161 | Abnormality of the renal cortex (HP:0011035) | 1.58251267 |
| 162 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.58200351 |
| 163 | Weak cry (HP:0001612) | 1.58197410 |
| 164 | Ventricular tachycardia (HP:0004756) | 1.57323798 |
| 165 | Abnormality of the renal medulla (HP:0100957) | 1.56325968 |
| 166 | Orchitis (HP:0100796) | 1.56120207 |
| 167 | Recurrent pneumonia (HP:0006532) | 1.55961777 |
| 168 | Postaxial foot polydactyly (HP:0001830) | 1.55912302 |
| 169 | Cutaneous syndactyly (HP:0012725) | 1.55877205 |
| 170 | Intestinal fistula (HP:0100819) | 1.55873320 |
| 171 | Renal tubular acidosis (HP:0001947) | 1.55522791 |
| 172 | Exercise intolerance (HP:0003546) | 1.55447105 |
| 173 | Dialeptic seizures (HP:0011146) | 1.54540379 |
| 174 | Abnormality of the labia minora (HP:0012880) | 1.54505689 |
| 175 | Absent septum pellucidum (HP:0001331) | 1.54492916 |
| 176 | Spinal rigidity (HP:0003306) | 1.53590427 |
| 177 | Type II lissencephaly (HP:0007260) | 1.52719017 |
| 178 | Paralysis (HP:0003470) | 1.46127742 |
| 179 | Fibular aplasia (HP:0002990) | 1.45814382 |
| 180 | Heart block (HP:0012722) | 1.43852891 |
| 181 | Hypokalemia (HP:0002900) | 1.43693851 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 5.16464418 |
| 2 | MKNK2 | 4.64669320 |
| 3 | TNIK | 3.98392877 |
| 4 | TTN | 3.19877135 |
| 5 | MKNK1 | 3.00240444 |
| 6 | MAP2K7 | 2.83379018 |
| 7 | OBSCN | 2.33164449 |
| 8 | ZAK | 2.27150280 |
| 9 | SIK3 | 2.25087170 |
| 10 | MAP3K14 | 2.19640607 |
| 11 | AKT3 | 2.19574623 |
| 12 | TXK | 2.10262185 |
| 13 | ADRBK2 | 1.90565661 |
| 14 | CDK8 | 1.85320778 |
| 15 | PRPF4B | 1.84873576 |
| 16 | MARK1 | 1.84832030 |
| 17 | INSRR | 1.81074235 |
| 18 | TAOK2 | 1.77782730 |
| 19 | BMPR2 | 1.74729178 |
| 20 | IRAK3 | 1.72805504 |
| 21 | BMPR1B | 1.71970739 |
| 22 | NEK6 | 1.63703335 |
| 23 | PLK2 | 1.62202415 |
| 24 | ERBB3 | 1.59123382 |
| 25 | MAP3K12 | 1.52099728 |
| 26 | MAPK13 | 1.49603581 |
| 27 | MAP3K7 | 1.45970260 |
| 28 | EIF2AK2 | 1.44854256 |
| 29 | YES1 | 1.40798013 |
| 30 | MAP4K2 | 1.39584731 |
| 31 | NTRK3 | 1.36375374 |
| 32 | WNK3 | 1.35033937 |
| 33 | STK16 | 1.33797709 |
| 34 | SGK2 | 1.33569672 |
| 35 | IRAK4 | 1.30661229 |
| 36 | PIK3CA | 1.28224916 |
| 37 | GRK7 | 1.26407409 |
| 38 | PIK3CG | 1.18368434 |
| 39 | MAPK7 | 1.09470314 |
| 40 | MAP3K4 | 1.08476736 |
| 41 | CDK3 | 1.06238910 |
| 42 | MAPKAPK3 | 1.05571062 |
| 43 | CCNB1 | 0.97266350 |
| 44 | STK38L | 0.96188587 |
| 45 | ACVR1B | 0.91799306 |
| 46 | TSSK6 | 0.90483215 |
| 47 | PRKCG | 0.89824399 |
| 48 | PRKAA2 | 0.88269758 |
| 49 | GRK1 | 0.87386697 |
| 50 | PRKCE | 0.83964757 |
| 51 | TNK2 | 0.83458706 |
| 52 | TEC | 0.83413948 |
| 53 | MAP3K13 | 0.82210468 |
| 54 | TRPM7 | 0.81831781 |
| 55 | MUSK | 0.79405459 |
| 56 | PINK1 | 0.79138901 |
| 57 | PKN1 | 0.77776492 |
| 58 | SGK223 | 0.75517529 |
| 59 | SGK494 | 0.75517529 |
| 60 | MAP3K6 | 0.74256075 |
| 61 | BRAF | 0.73298760 |
| 62 | TIE1 | 0.72337828 |
| 63 | BCKDK | 0.72210277 |
| 64 | NEK1 | 0.70930014 |
| 65 | PRKAA1 | 0.70638519 |
| 66 | CAMK4 | 0.68266247 |
| 67 | CAMK2G | 0.68219733 |
| 68 | NME1 | 0.68169297 |
| 69 | LIMK1 | 0.67658390 |
| 70 | MARK3 | 0.67029375 |
| 71 | EPHA4 | 0.66441017 |
| 72 | MAP2K6 | 0.64771956 |
| 73 | NUAK1 | 0.63420249 |
| 74 | MAPK12 | 0.62504069 |
| 75 | GRK5 | 0.61548864 |
| 76 | PAK3 | 0.61214029 |
| 77 | STK24 | 0.60819757 |
| 78 | BCR | 0.60361876 |
| 79 | STK39 | 0.60265493 |
| 80 | DAPK1 | 0.60198267 |
| 81 | SRPK1 | 0.59963986 |
| 82 | SGK1 | 0.58694360 |
| 83 | SGK3 | 0.57191810 |
| 84 | CAMK1 | 0.55531350 |
| 85 | DYRK1A | 0.55284080 |
| 86 | RPS6KB1 | 0.54330581 |
| 87 | PTK2B | 0.51040242 |
| 88 | EIF2AK3 | 0.50899375 |
| 89 | BRD4 | 0.50852838 |
| 90 | PLK4 | 0.49182211 |
| 91 | CAMK2A | 0.48962385 |
| 92 | EPHA3 | 0.48325633 |
| 93 | VRK1 | 0.48053386 |
| 94 | IKBKB | 0.47042177 |
| 95 | SYK | 0.43874027 |
| 96 | TGFBR1 | 0.43673600 |
| 97 | ROCK1 | 0.43581295 |
| 98 | MAP2K4 | 0.42671925 |
| 99 | PHKG2 | 0.42385171 |
| 100 | PHKG1 | 0.42385171 |
| 101 | CAMK2B | 0.41058678 |
| 102 | CLK1 | 0.40639497 |
| 103 | STK11 | 0.40138528 |
| 104 | TLK1 | 0.39982355 |
| 105 | CHUK | 0.39553094 |
| 106 | ADRBK1 | 0.39407200 |
| 107 | MAP2K1 | 0.38036991 |
| 108 | RIPK4 | 0.37376846 |
| 109 | MYLK | 0.37329212 |
| 110 | WNK4 | 0.37125389 |
| 111 | AKT2 | 0.36045933 |
| 112 | NLK | 0.35543715 |
| 113 | LYN | 0.34894074 |
| 114 | PNCK | 0.34670760 |
| 115 | DAPK2 | 0.34441621 |
| 116 | FES | 0.33474023 |
| 117 | PRKCQ | 0.33428659 |
| 118 | ATR | 0.32180063 |
| 119 | DMPK | 0.31073304 |
| 120 | PRKG1 | 0.30317427 |
| 121 | TRIM28 | 0.30113995 |
| 122 | PRKACA | 0.29581296 |
| 123 | RPS6KA3 | 0.28880416 |
| 124 | TAOK3 | 0.28627519 |
| 125 | MAPK15 | 0.28554985 |
| 126 | CDK19 | 0.28310737 |
| 127 | DYRK1B | 0.28081538 |
| 128 | MAPK4 | 0.28010728 |
| 129 | NEK9 | 0.27830555 |
| 130 | CSNK1G1 | 0.27754979 |
| 131 | CSNK1G2 | 0.26547330 |
| 132 | FRK | 0.26196364 |
| 133 | JAK1 | 0.25960989 |
| 134 | JAK3 | 0.24530745 |
| 135 | CSNK1A1 | 0.24305484 |
| 136 | KIT | 0.22955292 |
| 137 | DYRK2 | 0.22872145 |
| 138 | CAMK2D | 0.22699389 |
| 139 | LATS1 | 0.22435701 |
| 140 | PRKCD | 0.21729463 |
| 141 | MAP2K3 | 0.21672186 |
| 142 | PRKACG | 0.21546852 |
| 143 | PRKCB | 0.21162909 |
| 144 | PRKACB | 0.21126285 |
| 145 | OXSR1 | 0.20746066 |
| 146 | PDK2 | 0.19833982 |
| 147 | BRSK2 | 0.18770110 |
| 148 | MAPKAPK5 | 0.17748260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.59444687 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 3.46231188 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.65105166 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.38271234 |
| 5 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 2.34481364 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.34290118 |
| 7 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.33540548 |
| 8 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.28009634 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.26623134 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.20786843 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.18731537 |
| 12 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17007089 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.14464931 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02046159 |
| 15 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.95834078 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.91751740 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.90666287 |
| 18 | Parkinsons disease_Homo sapiens_hsa05012 | 1.84783738 |
| 19 | Circadian rhythm_Homo sapiens_hsa04710 | 1.81703961 |
| 20 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.80113302 |
| 21 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.76378072 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.75839278 |
| 23 | Taste transduction_Homo sapiens_hsa04742 | 1.72642079 |
| 24 | Olfactory transduction_Homo sapiens_hsa04740 | 1.70328881 |
| 25 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.69747366 |
| 26 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.67801341 |
| 27 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.67604986 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.67362858 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.65627525 |
| 30 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.64439870 |
| 31 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.64315671 |
| 32 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.62945292 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.62216425 |
| 34 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56061779 |
| 35 | GABAergic synapse_Homo sapiens_hsa04727 | 1.56044693 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.54010407 |
| 37 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.53539620 |
| 38 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.52888597 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.50653066 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46836992 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.46472293 |
| 42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.44844028 |
| 43 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38468985 |
| 44 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.37166833 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.32868423 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.29341859 |
| 47 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.28143641 |
| 48 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.25323674 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.22435770 |
| 50 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.22431898 |
| 51 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.22386593 |
| 52 | Insulin secretion_Homo sapiens_hsa04911 | 1.22118529 |
| 53 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.18605135 |
| 54 | Huntingtons disease_Homo sapiens_hsa05016 | 1.16623628 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.14458794 |
| 56 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14162001 |
| 57 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09335003 |
| 58 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.07180046 |
| 59 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.06987705 |
| 60 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06250797 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.03625482 |
| 62 | Asthma_Homo sapiens_hsa05310 | 1.03555998 |
| 63 | Insulin resistance_Homo sapiens_hsa04931 | 1.03220015 |
| 64 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.00744557 |
| 65 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99609978 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.98515796 |
| 67 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98084950 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.97609101 |
| 69 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.96271011 |
| 70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95952507 |
| 71 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.95780492 |
| 72 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95768648 |
| 73 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95378878 |
| 74 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93021976 |
| 75 | Measles_Homo sapiens_hsa05162 | 0.90610859 |
| 76 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.89389681 |
| 77 | Peroxisome_Homo sapiens_hsa04146 | 0.89102623 |
| 78 | Melanoma_Homo sapiens_hsa05218 | 0.89079592 |
| 79 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.87673762 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.84936977 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84835104 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83980375 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82699667 |
| 84 | Purine metabolism_Homo sapiens_hsa00230 | 0.82070774 |
| 85 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79563590 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79484221 |
| 87 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.78458325 |
| 88 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78137249 |
| 89 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77341573 |
| 90 | Homologous recombination_Homo sapiens_hsa03440 | 0.76732094 |
| 91 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.76639539 |
| 92 | Carbon metabolism_Homo sapiens_hsa01200 | 0.74438305 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74030873 |
| 94 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73141657 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.72779020 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.72385066 |
| 97 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.72296442 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.71762959 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70970593 |
| 100 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69564506 |
| 101 | Salivary secretion_Homo sapiens_hsa04970 | 0.69354224 |
| 102 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.68671295 |
| 103 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.68087657 |
| 104 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.67337205 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66976473 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.66888761 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.66540834 |
| 108 | Influenza A_Homo sapiens_hsa05164 | 0.66450093 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65759181 |
| 110 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.65688338 |
| 111 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64801082 |
| 112 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.64045845 |
| 113 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63913498 |
| 114 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63494571 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.62969115 |
| 116 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.62259644 |
| 117 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61659028 |
| 118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.60818814 |
| 119 | Long-term depression_Homo sapiens_hsa04730 | 0.60006752 |
| 120 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59592736 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.59006696 |
| 122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58842557 |
| 123 | Tuberculosis_Homo sapiens_hsa05152 | 0.58542795 |
| 124 | Malaria_Homo sapiens_hsa05144 | 0.58295892 |
| 125 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56529888 |
| 126 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.55614851 |
| 127 | Long-term potentiation_Homo sapiens_hsa04720 | 0.55074312 |
| 128 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.54907931 |
| 129 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53417495 |
| 130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.53335966 |
| 131 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51469210 |
| 132 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.50447638 |
| 133 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.48897173 |
| 134 | RNA polymerase_Homo sapiens_hsa03020 | 0.48628233 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47028603 |
| 136 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46547649 |
| 137 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.43862967 |
| 138 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.43563293 |
| 139 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.43543403 |
| 140 | Lysine degradation_Homo sapiens_hsa00310 | 0.42860317 |
| 141 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.42640848 |
| 142 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42012242 |
| 143 | Metabolic pathways_Homo sapiens_hsa01100 | 0.41943961 |
| 144 | Base excision repair_Homo sapiens_hsa03410 | 0.40850652 |
| 145 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40429436 |
| 146 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.40233561 |
| 147 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.39598225 |
| 148 | RNA degradation_Homo sapiens_hsa03018 | 0.39178987 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39013097 |
| 150 | Viral myocarditis_Homo sapiens_hsa05416 | 0.37456860 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | 0.36962889 |
| 152 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.36911285 |
| 153 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.36742271 |
| 154 | Alzheimers disease_Homo sapiens_hsa05010 | 0.36531354 |
| 155 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34889462 |
| 156 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34652057 |
| 157 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33236351 |
| 158 | Salmonella infection_Homo sapiens_hsa05132 | 0.32983713 |

